Trial · NCT07222761
Registered outcomes44
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 44
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Occurrence of Treatment Emergent Adverse Events (TEAEs) | Up to 5 years | Part 1 |
| Primary | Severity of TEAEs | Up to 5 years | Part 1 |
| Primary | Occurrence of Adverse Events of Special Interest (AESI) | Up to 5 years | Part 1 |
| Primary | Severity of AESIs | Up to 5 years | Part 1 |
| Primary | Occurrence of Serious Adverse Events (SAEs) | Up to 5 years | Part 1 |
| Primary | Severity of SAEs | Up to 5 years | Part 1 |
| Primary | Minimal Residual Disease (MRD)-negative Complete Response (CR) | At 12 months | Part 2 |
| Primary | Progression-Free Survival (PFS) per IMWG response criteria as determined by BIRC | Up to 5 years | Part 2 |
| Secondary | Occurrence of grade ≥2 Cytokine Release Syndrome (CRS) | Up to 28 days | Part 1 |
| Secondary | Timing of grade ≥2 CRS | Up to 28 days | Part 1 |
| Secondary | Overall Survival (OS) | Up to 7 years | Part 2 |
| Secondary | Achievement of Partial Response (PR) or better per IMWG response criteria as determined by BIRC | Up to 5 years | Part 2 |
| Secondary | Achievement of Very Good Partial Response (VGPR) or better per IMWG response criteria as determined by BIRC | Up to 5 years | Part 2 |
| Secondary | Achievement of CR or better per IMWG response criteria as determined by BIRC | Up to 5 years | Part 2 |
| Secondary | Duration Of Response (DOR) as per IMWG response criteria | Up to 5 years | Part 2 |
| Secondary | Time To Progression (TTP) as per IMWG response criteria | Up to 5 years | Part 2 |
| Secondary | Time To Next Treatment (TTNT) | Up to 5 years | Part 2 |
| Secondary | Second PFS | Up to 5 years | Part 2 |
| Secondary | MRD-negative CR criteria at any time | Up to 5 years | Part 2 |
| Secondary | Time to PR IMWG response category | Up to 5 years | Part 2 |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07222761/registered